• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Attention Deficit Disorder with Hyperactivity

Attention Deficit Disorder with Hyperactivity - 737 Studies Found

Completed : NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2013-04-08
:
  • Drug: NT0102 One or two tablet

Active, not recruiting : Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2014-10-02
:
  • Other: Vayarin® Medical F

Completed : Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2008-09-12
: Drug: Lisdexamfetamine Lisdexamfetamine daily until the completion of participation in the clinical tria
Completed : Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2011-03-29
: Drug: Lisdexamfetamine dimesylate Optimized dose of either 30, 50 or 70 mg capsule administered once dai
Completed : The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2016-05-12
:
  • Drug: Methylphenidate compounds and /or Amphetamine compounds and/or Stratte

Completed : Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
: Attention Deficit/Hyperactivity Disorder
: 2010-12-11
:
  • Drug: Placebo Placebo Comparat

Completed : Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2015-06-04
: Drug: SPD489 SPD489 will be provided in 5, 10, 15, 20, and 30mg strength capsules. Subjects will be inst
Completed : Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2015-11-11
:
  • Drug: SHP465 12.5mg capsules (one capsule daily)

Completed : Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine
: Attention-deficit/Hyperactivity Disorder
: 2010-06-15
: Drug: Guanfacine (sustained release) Treated with study drug once screening and initial testing is compl
Completed : The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder
: Attention Deficit/Hyperactivity Disorder (ADHD)
: 2006-12-31
:
  • Dietary Supplement: Phosphatidylserine-Omega3

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.